Lung squamous cell carcinoma with hemoptysis after vaccination with tozinameran (BNT162b2, Pfizer‐BioNTech)

A 66‐year‐old man with squamous cell carcinoma had been receiving chemoradiation therapy after stereotactic radiotherapy for brain metastases. Atezolizumab was initiated as second‐line therapy, after which the patient became progression‐ and recurrence‐free. Four days after his second dose of tozina...

Descripción completa

Detalles Bibliográficos
Autores principales: Sumi, Toshiyuki, Nagahisa, Yuta, Matsuura, Keigo, Sekikawa, Motoki, Yamada, Yuichi, Nakata, Hisashi, Chiba, Hirofumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8590897/
https://www.ncbi.nlm.nih.gov/pubmed/34612003
http://dx.doi.org/10.1111/1759-7714.14179

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8590897/
https://www.ncbi.nlm.nih.gov/pubmed/34612003
http://dx.doi.org/10.1111/1759-7714.14179

Ejemplares similares